Association of body mass index on 10-year outcomes in patients treated with percutaneous coronary intervention and drug-eluting stents (the DECADE cooperation) - Scorecard - MDSpire

Association of body mass index on 10-year outcomes in patients treated with percutaneous coronary intervention and drug-eluting stents (the DECADE cooperation)

  • By

  • Maria Scalamogna

  • Fiorenzo Simonetti

  • John Joseph Coughlan

  • Luis Ortega-Paz

  • Lorenz Räber

  • Lisette Okkels Jensen

  • Michael Maeng

  • Salvatore Brugaletta

  • Sebastian Kufner

  • Sarah Bär

  • Karl-Ludwig Laugwitz

  • Dik Heg

  • Manel Sabaté

  • Stephan Windecker

  • Kevin Kris Warnakula Olesen

  • Adnan Kastrati

  • Salvatore Cassese

  • November 24, 2025

  • 0 min

Share

Clinical Scorecard: Impact of Body Mass Index on Decadal Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Findings from the DECADE Collaboration

At a Glance

CategoryDetail
ConditionCoronary artery disease treated with percutaneous coronary intervention (PCI) using drug-eluting stents (DES)
Key MechanismsBody mass index (BMI) influences long-term mortality, cardiovascular death, stent thrombosis, and repeat revascularization outcomes after PCI with DES
Target PopulationPatients undergoing PCI with DES implantation, categorized by BMI (underweight, normal-weight, overweight, obese)
Care SettingCardiology interventional units and long-term secondary prevention clinics

Key Highlights

  • 10-year all-cause mortality was highest in underweight patients and lowest in overweight patients after PCI with DES.
  • Overweight and obese patients had increased risk of definite stent thrombosis within 30 days post-PCI.
  • Obese patients had a lower risk of repeat revascularization compared to normal-weight patients.

Guideline-Based Recommendations

Diagnosis

  • Assess baseline BMI in patients undergoing PCI with DES to stratify long-term risk.

Management

  • Consider BMI category in tailoring secondary prevention strategies post-PCI.
  • Monitor overweight and obese patients closely for early stent thrombosis.

Monitoring & Follow-up

  • Long-term follow-up (up to 10 years) for mortality and cardiovascular events according to BMI category.
  • Early surveillance for stent thrombosis within 30 days in overweight and obese patients.

Risks

  • Underweight patients have increased long-term mortality risk post-PCI.
  • Overweight and obese patients have higher early stent thrombosis risk.
  • Obese patients have reduced risk of repeat revascularization.

Patient & Prescribing Data

9486 patients from five randomized trials undergoing PCI with DES, categorized by BMI

BMI influences long-term outcomes; overweight status associated with lower mortality, while underweight status is linked to higher mortality; obese patients show mixed risk profiles including higher early stent thrombosis but lower repeat revascularization.

Clinical Best Practices

  • Incorporate BMI measurement as a routine part of pre-PCI assessment.
  • Recognize the U-shaped relationship between BMI and mortality to inform risk stratification.
  • Implement targeted secondary prevention strategies considering BMI-related risks.
  • Ensure vigilant early post-PCI monitoring for stent thrombosis in overweight and obese patients.
  • Promote further research to clarify mechanisms and optimize management based on BMI.

References

Original Source(s)

Related Content